A deep dive into the Masters win probability prediction market at Kalshi, including analysis on favorites, longshots, and who ...
AnaptysBio is splitting into a high-margin royalty company and a pipeline-focused biopharma, each with distinct valuation ...
Tashas Group CEO Natasha Sideris on navigating a 30 per cent revenue drop, cutting costs and staying on track for expansion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results